4.4 Article

Intravascular cells and circulating microparticles induce procoagulant activity via phosphatidylserine exposure in heart failure

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure

Batric Popovic et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Red blood cell distribution width in heart failure: A narrative review

Giuseppe Lippi et al.

WORLD JOURNAL OF CARDIOLOGY (2018)

Article Clinical Neurology

Enhanced Procoagulant Activity on Blood Cells after Acute Ischemic Stroke

Zhipeng Yao et al.

TRANSLATIONAL STROKE RESEARCH (2017)

Review Peripheral Vascular Disease

Role of Inflammation in Heart Failure

Lily F. Shirazi et al.

CURRENT ATHEROSCLEROSIS REPORTS (2017)

Article Pathology

Tissue factor is unregulated in microvascular endothelial cells of patients with heart failure

Edyta Reichman-Warmusz et al.

JOURNAL OF CLINICAL PATHOLOGY (2016)

Article Medicine, General & Internal

Circulating annexin A5 predicts mortality in patients with heart failure

L. J. Schurgers et al.

JOURNAL OF INTERNAL MEDICINE (2016)

Review Cardiac & Cardiovascular Systems

Non-vitamin K antagonist oral anticoagulants and heart failure

Richard Isnard et al.

ARCHIVES OF CARDIOVASCULAR DISEASES (2016)

Article Medical Laboratory Technology

Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure

Alexander E. Berezin et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)

Article Cardiac & Cardiovascular Systems

Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients

Alexander E. Berezin et al.

JOURNAL OF CARDIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Micropartículas de pequeño tamaño como indicadores del estado agudo en la insuficiencia cardiaca sistólica

Silvia Montoro-García et al.

REVISTA ESPANOLA DE CARDIOLOGIA (2015)

Review Medical Laboratory Technology

Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers

Giuseppe Lippi et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2014)

Article Hematology

Fractalkine promotes platelet activation and vascular dysfunction in congestive heart failure

Steven K. Hildemann et al.

THROMBOSIS AND HAEMOSTASIS (2014)

Article Cardiac & Cardiovascular Systems

Anticoagulation in heart failure: current status and future direction

Mihai Gheorghiade et al.

HEART FAILURE REVIEWS (2013)

Review Peripheral Vascular Disease

Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells

Dylan Burger et al.

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2012)

Editorial Material Medicine, General & Internal

Does cardiac insufficiency receive AVK?

Helene Vaillant-Roussel et al.

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)

Article Medicine, General & Internal

Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm

Shunichi Homma et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Cardiac & Cardiovascular Systems

Bone marrow dysfunction in chronic heart failure patients

B. Daan Westenbrink et al.

EUROPEAN JOURNAL OF HEART FAILURE (2010)

Article Cardiac & Cardiovascular Systems

Prognostic value of endothelial microparticles in patients with heart failure

Toshimitsu Nozaki et al.

EUROPEAN JOURNAL OF HEART FAILURE (2010)

Article Hematology

Platelet activation in acute, decompensated congestive heart failure

Irene Chung et al.

THROMBOSIS RESEARCH (2007)

Article Cardiac & Cardiovascular Systems

Platelet activation in patients with congestive heart failure: Do we have enough evidence to consider clopidogrel?

AI Malinin et al.

AMERICAN HEART JOURNAL (2003)

Article Medicine, General & Internal

Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

GM Felker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)